Propranolol for Treatment of Cocaine Addiction - 2
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Propranolol (Drug)
Phase: Phase 2
Status: Active, not recruiting
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Kyle Kampman, M.D., Principal Investigator, Affiliation: University of Pennsylvania
Summary
The purpose of this study is to evaluate the safety and efficacy of propanolol in the early
treatment of cocaine dependence.
Clinical Details
Official title: Propranolol for Treatment of Cocaine Addiction
Study design: Treatment
Primary outcome: Side effectsCocaine use Cocaine withdrawal Cocaine craving Mood and anxiety Clinical improvement
Eligibility
Minimum age: 25 Years.
Maximum age: 49 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
University of Pennsylvania, Philadelphia, Pennsylvania 19104 6178, United States
Additional Information
Starting date: January 1987
Last updated: August 16, 2005
|
